Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis-Reference-Cited by-同舟云学术

Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis

Published:1992-11 Issue:5 Volume:43 Page:555-558
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Ljubičić N.,Bilić A.,Plavšić V.,Ljubičić N.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02285102.pdf

Reference17 articles.

1. Lebrec D, Poynard T, Hillon P (1984) A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A final report. Hepatology 4: 355–338

2. Colombo M, DeFranchis R, Tommasini M, Sangiovanni A, Dioguardi N (1989) Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial. Hepatology 9: 433–438

3. Westaby D, Bihari DJ, Gimson AES, Crossley IR, Williams R (1984) Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Gut 25:121–124

4. Buhler FR, Larage JH, Baer L, Vaughan ED, Brunner HR (1972) Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med 287:1209–1214

5. Wilkinson SP, Bernadi M, Smith IK, Jowett TP, Slater JDH, Williams R (1977) Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites. Gastroenterology 73: 659–663

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemodynamic effects of renin-angiotensin-aldosterone inhibitor and β-blocker combination therapy vs. β-blocker monotherapy for portal hypertension in cirrhosis: A meta-analysis;Experimental and Therapeutic Medicine;2017-03-09

2. Pharmacokinetic Aspects of Treating Infections in the Intensive Care Unit;Clinical Pharmacokinetics;2001

3. Acute and chronic effects of isosorbide‐5‐mononitrate administration on effective renal plasma flow and the renin‐aldosterone system in cirrhotic patients;Journal of Gastroenterology and Hepatology;2000-09

4. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures;Journal of Antimicrobial Chemotherapy;2000-03

5. Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis;Journal of Hepatology;1999-03